[Sending recorded video] Cutting-edge mRNA therapeutics - Next-generation purification technology utilizing Monoliths
Participation in this webinar has ended. If you wish to view it, please contact us. We will send you the URL for the recorded video at a later date.
During the COVID-19 pandemic, mRNA-based vaccines have been widely recognized by the biopharmaceutical industry and regulatory authorities. However, in downstream process development, there are challenges to address in order to manufacture affordable and safe mRNA-based vaccines using scalable and robust purification processes. We aim to introduce solutions that can be provided using our CIM monolith and develop a scalable and robust downstream purification process from pDNA to mRNA.
▪ Method of holding: Webinar recorded broadcast [in Japanese, free of charge]
*We sincerely apologize, but participation from individuals using email addresses other than those from your company or organization is not permitted. Thank you for your understanding.

| Date and time | Thursday, May 26, 2022 03:00 PM ~ |
|---|---|
| Entry fee | Free |
Inquiry about this news
Contact Us OnlineMore Details & Registration
Details & Registration
Related product
Related catalog(15)




